Psoriasis is a common chronic and systemic immune-mediated disease, induced by a combination of genetic and environmental effects. The increasingly worrying question is the negative impact on patients' sleep, which has become an important comorbidity of psoriasis. To investigate the causal relationship between psoriasis and sleep status, a prospective cohort study will be conducted by separating moderate-to-severe psoriasis patients and healthy individuals into distinct cohorts in order to observe their sleep status.
Target follow-up duration for the study is 24 weeks, during which participants will undergo a sleep monitoring session every 8 weeks. The sleep monitoring data collected includes time to fall asleep, time to bed, sleep perception, and the Pittsburgh Sleep Quality Index (PSQI). The Dermatology Quality of Life Index (DLQI), the Psoriasis Area and Severity Index (PASI), and the Visual Analog Scale (VAS) will simultaneously be used to assess the severity of the disease in the cohort of patients with psoriasis.
Study Type
OBSERVATIONAL
Enrollment
156
This is an observational study, no intervention will be implemented.
This is an observational study, no intervention will be implemented.
Shanghai Yueyang Integrated Medicine Hospital
Shanghai, Shanghai Municipality, China
Pittsburgh sleep quality index (PSQI)
PSQI is a 19-item self-rated questionnaire for evaluating subjective sleep quality over the previous month. A score above 5 suggests poor sleep quality.
Time frame: week0、week8、week16、week24
Psoriasis Area and Severity Index (PASI)
The PASI score ranges from 0 to 72, and the higher the score, the more serious the patient's condition. Generally speaking, a PASI score of less than 10 indicates mild psoriasis, 10-20 indicates moderate psoriasis, and more than 20 indicates severe psoriasis.
Time frame: week0、week8、week16、week24
Dermatology Life Quality Index (DLQI)
DLQI was a participant-reported questionnaire used to measure the health-related quality of life (QOL) of adults suffering from a skin disease. Scores ranged from 0-30, a higher score indicating a greater impact on a participant's QOL.
Time frame: week0、week8、week16、week24
Visual Analogue Scale (VAS)
The scoring criteria for pruritus level are as follows: absence of pruritus = 0; mild (intermittent itching, no scratching, no interference with daily activities) = 1-3 points; moderate (frequent itching, occasional scratching, impacting daily routine and sleep) = 4-6 points, and severe (intense itching, persistent scratching, significantly affecting daily life and sleep) = 7-10 points.
Time frame: week0、week8、week16、week24
Hospital Anxiety and Depression Scale(HADS)
For describing depression and anxiety in hospital patients
Time frame: week0、week8、week16、week24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.